Over 16 million children across Kenya have been vaccinated against typhoid following the successful completion of a nationwide immunization campaign. The government has now made the vaccine freely available in all health facilities offering routine immunization services.
Highlights:
- 16.1 million children received the typhoid vaccine
- The campaign targeted children aged 9 months to 15 years
- The vaccine is now part of Kenya’s routine immunization schedule
- It is available free of charge at all immunizing health facilities
Main Story:
Kenya has wrapped up one of its most ambitious public health campaigns, with 16.1 million children vaccinated against typhoid across all 47 counties. The campaign, which targeted children aged between 9 months and 15 years, marks a significant milestone in the country’s efforts to control waterborne diseases.
Health officials say the high turnout reflects growing public awareness about the importance of immunization in preventing typhoid, which remains a major health concern in many parts of the country.
With the mass campaign now concluded, the Ministry of Health has confirmed that the typhoid vaccine will be integrated into routine child immunization services nationwide. Parents and guardians can now access the vaccine for free at all designated public health facilities.
Health workers have been trained to administer the vaccine safely, and adequate stocks have been distributed to ensure a smooth transition from the campaign to regular immunization.
The rollout is expected to drastically reduce typhoid infections, especially in high-risk areas with limited access to clean water and sanitation. Health experts have hailed the campaign as a game-changer for public health, especially among school-aged children who are most vulnerable to the disease.
Officials are now urging parents to continue bringing their children for routine vaccinations and to maintain proper hygiene practices as part of broader typhoid prevention efforts.
Read Also:
- WHO Selects Kenya for Early Access to Breakthrough HIV PrEP Drug
- Vaccines Arrive in Kenya After Months of Critical Shortages
You Might Have Missed This:
- FDA Approves Yeztugo: A Twice-Yearly HIV Prevention Shot
- Closing the Gap: Why Kenya’s HIV Battle Now Targets Men
Vaccines don’t just save lives — they secure futures.
